Infervision

Infervision is a pioneering artificial intelligence company focusing on medical AI solutions with the mission to enhance human life through AI. The company, founded in 2015 and headquartered in the United States, is dedicated to leveraging deep learning technology to provide efficient and accurate medical image diagnosis solutions. It has introduced innovative products such as the "Infervision - artificial intelligence precise healthcare platform," intelligent X-ray assisted diagnosis, and intelligent CT assisted diagnosis products. These offerings have been widely adopted, with deployment in hundreds of hospitals worldwide, leading to improved diagnosis efficiency and accuracy. Infervision not only excels in product development but also actively engages in academic research and maintains deep collaborations with top institutions in Chinese Radiology, combining medical science and medical technology. The company has fostered business partnerships with approximately 250 top hospitals globally, spanning Asia, North America, and Europe. The recent milestone of securing a $140.00M Series D investment on 23 July 2021 from impressive investors including Goldman Sachs Asset Management, CCB Trust, and Z-Park Fund underscores the confidence in Infervision's potential to drive breakthroughs in artificial intelligence application in healthcare. With its strong market position and proven track record, Infervision is poised to continue making significant strides in the healthcare industry, ushering in a new era of medical diagnosis and treatment through the power of AI.